Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif–containing 21
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif–containing 21
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 293, Issue 17, Pages 6556-6564
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2018-03-07
DOI
10.1074/jbc.ra117.000245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis
- (2017) Lorenzo Nicole et al. Oncotarget
- SALL4, the missing link between stem cells, development and cancer
- (2016) Hiro Tatetsu et al. GENE
- TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis
- (2016) Ji-An Pan et al. MOLECULAR CELL
- SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis
- (2016) MENGYUAN YANG et al. ONCOLOGY REPORTS
- Functional and clinical significance of SALL4 in breast cancer
- (2016) Ebubekir Dirican et al. TUMOR BIOLOGY
- BMI-1, a promising therapeutic target for human cancer
- (2015) MIN-CONG WANG et al. Oncology Letters
- MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1
- (2015) Yancheng Lin et al. Scientific Reports
- Identification of the nuclear localization signal of SALL4B, a stem cell transcription factor
- (2014) Meng Wu et al. CELL CYCLE
- TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms
- (2014) Elisa Lazzari et al. PLoS One
- Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex
- (2013) C. Gao et al. BLOOD
- Sal-like 4(SALL4) suppressesCDH1expression and maintains cell dispersion in basal-like breast cancer
- (2013) Junji Itou et al. FEBS LETTERS
- Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4
- (2013) Jie He et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma
- (2013) Kol Jia Yong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation
- (2012) Catherine H Wilson et al. EMBO JOURNAL
- Sumoylation Is Important for Stability, Subcellular Localization, and Transcriptional Activity of SALL4, an Essential Stem Cell Transcription Factor
- (2012) Feikun Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- A Novel SALL4/OCT4 Transcriptional Feedback Network for Pluripotency of Embryonic Stem Cells
- (2010) Jianchang Yang et al. PLoS One
- Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)
- (2010) D. L. Mallery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities
- (2009) Roland Hjerpe et al. EMBO REPORTS
- Signal transducer and activator of transcription 3 is a transcriptional factor regulating the gene expression of SALL4
- (2009) J. Dien Bard et al. FASEB JOURNAL
- Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
- (2009) Jiayun Lu et al. PLoS One
- Sall1, Sall2, and Sall4 Are Required for Neural Tube Closure in Mice
- (2008) Johann Böhm et al. AMERICAN JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started